Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
12/09/2024 | 22:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PODD | Insulet Corporation |
11/09/2024 | 21:40 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:PODD | Insulet Corporation |
26/08/2024 | 22:20 | Business Wire | Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes | NASDAQ:PODD | Insulet Corporation |
20/08/2024 | 12:00 | Business Wire | Insulet to Present at Upcoming Investor Conferences | NASDAQ:PODD | Insulet Corporation |
14/08/2024 | 09:00 | Business Wire | Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia | NASDAQ:PODD | Insulet Corporation |
09/08/2024 | 11:48 | IH Market News | Sweetgreen Rises 22% on Raised Forecasts, Doximity Jumps 30%, Rocket Lab Soars 14% on 71% Revenue Growth, and More | NASDAQ:PODD | Insulet Corporation |
08/08/2024 | 22:03 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PODD | Insulet Corporation |
08/08/2024 | 22:01 | Business Wire | Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year | NASDAQ:PODD | Insulet Corporation |
26/07/2024 | 12:00 | Business Wire | Insulet Reports Preliminary Second Quarter 2024 Revenue Results | NASDAQ:PODD | Insulet Corporation |
08/07/2024 | 12:00 | Business Wire | Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024 | NASDAQ:PODD | Insulet Corporation |
22/06/2024 | 00:30 | Business Wire | Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes | NASDAQ:PODD | Insulet Corporation |
20/06/2024 | 12:05 | Business Wire | Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands | NASDAQ:PODD | Insulet Corporation |
20/06/2024 | 12:00 | Business Wire | Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates | NASDAQ:PODD | Insulet Corporation |
28/05/2024 | 12:00 | Business Wire | Insulet to Present at the Jefferies Global Healthcare Conference | NASDAQ:PODD | Insulet Corporation |
10/05/2024 | 13:58 | IH Market News | JFrog and Akamai Drop Over 10% Despite Strong Profits; Sweetgreen, Array, SoundHound Surge, and More in Earnings | NASDAQ:PODD | Insulet Corporation |
09/05/2024 | 22:01 | Business Wire | Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year | NASDAQ:PODD | Insulet Corporation |
07/05/2024 | 12:00 | Business Wire | Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth | NASDAQ:PODD | Insulet Corporation |
03/04/2024 | 12:00 | Business Wire | Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 | NASDAQ:PODD | Insulet Corporation |
20/03/2024 | 11:00 | Business Wire | Insulet Appoints Ana Maria Chadwick as Chief Financial Officer | NASDAQ:PODD | Insulet Corporation |
08/03/2024 | 12:00 | Business Wire | Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy | NASDAQ:PODD | Insulet Corporation |
05/03/2024 | 12:00 | Business Wire | Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) | NASDAQ:PODD | Insulet Corporation |
23/02/2024 | 14:03 | IH Market News | Goldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and More | NASDAQ:PODD | Insulet Corporation |
22/02/2024 | 22:07 | Business Wire | Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency) | NASDAQ:PODD | Insulet Corporation |
13/02/2024 | 22:01 | Business Wire | Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference | NASDAQ:PODD | Insulet Corporation |
10/02/2024 | 00:19 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:PODD | Insulet Corporation |
07/02/2024 | 12:00 | Business Wire | Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor | NASDAQ:PODD | Insulet Corporation |
22/01/2024 | 22:07 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:PODD | Insulet Corporation |
18/01/2024 | 22:01 | Business Wire | Insulet Announces Changes to Board of Directors with Retirements and New Appointments | NASDAQ:PODD | Insulet Corporation |
11/01/2024 | 12:00 | Business Wire | Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 | NASDAQ:PODD | Insulet Corporation |
03/11/2023 | 12:32 | IH Market News | Friday’s Wall Street Highlights: Apple, Bill Holdings, Paramount, Block, and more | NASDAQ:PODD | Insulet Corporation |